Paasa Logo
Immutep Limited logo
IMMPNASDAQMarket closedOpens 9:30am ET

Immutep Limited

$0.26Last updated
+$0.00 (0.57%)Past day
Timezone

Immutep Limited (NASDAQ: IMMP) is trading at $0.26, about ₹25 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.57% today. Indian residents can buy Immutep from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$0.28
Previous close:$0.26
Volume:648.29K

Today's low

$0.26

Today's high

$0.28

52 week low

$0.26

52 week high

$3.53

IMMP opened at $0.28, closed previously at $0.26, and has traded between $0.26 and $3.53 over the past 52 weeks.

About

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

Country
AU
CEO
Marc Voigt
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
53
Sector
Healthcare
IPO date
19/04/2012

Key statistics

Avg. volume

426.82K

Market cap

$38.83M

P/E Ratio

-0.67

Price-to-sales ratio

3.64

Enterprise value

-A$14.77M

Free cash flow yield

-104.72%

Debt-to-equity ratio

0.02

Return on equity

-98.86%

ROIC

-125.32%

Beta

2.25

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

A$14.24M

Earnings per share

-A$0.53

Free cash flow

-A$54.34M

Net profit margin

-544.79%

Gross margin

84.97%

EBITDA

-A$79.63M

Revenue growth

182.31%

Similar securities

This is not an investment recommendation

How to buy Immutep from India

Indian residents can buy Immutep shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Immutep and place an order

    Find Immutep by name or by its ticker, IMMP, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Immutep trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Immutep position in USD and INR. Immutep pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Immutep from India

Trading and taxes when buying Immutep from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneImmutep does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Immutep stock?

Yes. Immutep (IMMP) has been listed on NASDAQ since 2012, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Immutep share cost in rupees?

One Immutep share is $0.26 — about ₹25 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the Immutep price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Immutep from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Immutep?

Yes. One Immutep share is $0.26, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Immutep.

How are gains on Immutep shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Immutep price. Paasa issues a capital-gains statement for your return.

Does Immutep pay a dividend?

No. Immutep does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Immutep from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is Immutep a United States company, and does that change how it is taxed?

Immutep trades on NASDAQ in US dollars, but the company is domiciled in Australia. Immutep trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare Immutep shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Immutep holding, its cost and its closing value.

How do I sell Immutep and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.